Acute Fatty Liver of Pregnancy (AFLP) represents a high-stakes medical emergency where swift and strategic emergency treatments for AFLP can mean the difference between life and death for both mother and child. This rare but potentially fatal condition demands immediate, precise medical intervention that combines diagnostic acuity with rapid therapeutic response.
AFLP emerges as a swift, sink-or-swim scenario in late pregnancy, typically manifesting between weeks 28 and 40. The condition triggers massive hepatic dysfunction, creating a cascade of metabolic disruptions that challenge even the most seasoned clinicians. Mitochondrial dysfunction, particularly related to long-chain fatty acid metabolism, sets the stage for this life-threatening complication.
Diagnosis of AFLP involves a combination of clinical suspicion and diagnostic criteria such as the Swansea criteria. These include symptoms like low blood sugar, elevated bilirubin, and abnormal clotting times. An ultrasound may show a hyperechoic liver, but the condition’s emergency nature often necessitates proceeding based on clinical findings. Once diagnosed, initiating emergency treatments for AFLP is imperative.
Maternal stabilization is the immediate priority. This includes:
These interventions buy time, allowing for a smoother transition to definitive treatments.
The most effective way to halt the progression of AFLP is delivery of the baby. Once the fetus is delivered, the metabolic strain on the mother’s liver decreases, often leading to rapid improvement in her condition. The mode of delivery depends on the mother’s stability and gestational age:
In one case I encountered, a 35-year-old mother at 36 weeks of gestation presented with severe hypoglycemia and altered mental status. An immediate cesarean delivery, followed by supportive care, stabilized her condition within 48 hours. This case highlighted how swift decisions and teamwork are pivotal.
AFLP can lead to complications in several organ systems. Addressing these simultaneously is a challenge, requiring a multidisciplinary approach:
Each step must be tailored to the patient’s evolving clinical status, with a focus on preventing irreversible damage.
Patients with AFLP require close monitoring in an intensive care setting. Continuous evaluation of vital signs, liver function tests, and coagulation parameters ensures early detection of complications. This hands-on, eyes-on approach can catch subtle shifts before they spiral out of control.
In severe cases, plasmapheresis has emerged as a promising adjunctive therapy. By removing toxic substances and correcting coagulopathy, it helps bridge the gap until the liver recovers. However, its availability may be limited, and its use depends on the severity of the case and institutional protocols.
Beyond the physical toll, AFLP leaves a psychological impact on many mothers. Surviving a near-fatal condition can trigger postpartum anxiety or depression. Addressing these needs is as important as managing the physical aftermath.
Postpartum liver function usually normalizes, but follow-up is crucial. Patients should undergo genetic counseling, particularly when LCHAD enzyme mutations are implicated, to assess risks for future pregnancies.
The most effective emergency treatments for AFLP center around stabilizing the mother, promptly delivering the baby, and addressing complications:
With a well-coordinated team and vigilant monitoring, most mothers and babies recover fully.
With timely emergency medical management for AFLP, maternal survival rates approach 70-80%. However, the condition carries significant risk of recurrence in subsequent pregnancies, necessitating comprehensive genetic counseling and preconception planning.
AFLP, though rare, demands urgent attention due to its life-threatening nature. As medical professionals, we must maintain a high index of suspicion in pregnant patients with liver dysfunction symptoms. Timely intervention and a collaborative approach can turn a potential tragedy into a success story.
Share this article
Dr. Alinda Mae Gordola, MD
I am a board-certified internist and gastroenterologist specializing in the diagnosis and treatment of digestive system disorders. See Full Bio.
Risk Factors for Developing AFLP AFLP emerges as a multifactorial disorder characterized by rapid hepatic lipid accumulation during pregnancy.
How AFLP Affects the Mother and Baby Understanding how AFLP affects the mother and baby is crucial for medical professionals and expectant...
Recognizing Early Symptoms of AFLP Acute Fatty Liver of Pregnancy (AFLP) is a rare but serious condition that can emerge during the third...
You might enjoy more articles by
Dr. Alinda Mae Gordola, MD